Over Expression of Hypoxia-Inducible Protein 2, Hypoxia-Inducible Factor-1α and Nuclear Factor κB is Putatively Involved in Acquired Renal Cyst Formation and Subsequent Tumor Transformation in Patients With End Stage Renal Failure

Journal of Urology

Volumn 180, Issue 2, 2008, Pages 481-485

  Konda, Ryuichiro ^a   Sugimura, Jun ^a   Sohma, Fumihiko ^a   Katagiri, Toyomasa ^a   Nakamura, Yusuke ^a   Fujioka, Tomoaki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

carcinoma, renal cell; cysts; HIG2 protein, human; kidney; kidney failure

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY CYST; KIDNEY EPITHELIUM; KIDNEY FAILURE; KIDNEY PAPILLA; KIDNEY TUBULE CELL; KIDNEY TUMOR; MALE; NEPHRECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION;

ADULT; AGED; BIOPSY, NEEDLE; CARCINOMA, RENAL CELL; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES, CYSTIC; KIDNEY FAILURE, CHRONIC; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEPHRECTOMY; NF-KAPPA B; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 46749084588     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.04.006     Document Type: Article

References (20)

1. Ishikawa I. Acquired cystic disease: mechanism and manifestation. Semin Nephrol 6 (1991) 671
2. Truong L.D., Krishnan B., Cao J.T.H., Barrios R., and Suki W.N. Renal neoplasm in acquired cystic disease. Am J Kidney Dis 26 (1995) 1
3. Stewart J.H., Buccianti G., Agodoa L., Gellert R., Mccredie M.R.E., Lowenfels A.B., et al. Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 14 (2003) 197
4. Konda R., Sato H., Hatafuku F., Nozawa T., Ioritani N., and Fujioka T. Expression of hepatocyte growth factor and its receptor c-met in acquired renal cystic disease associated with renal cell carcinoma. J Urol 171 (2004) 2166
5. Togashi A., Katagiri T., Ashida S., Fujioka T., Maruyama O., Wakumoto Y., et al. Hypoxia-inducible protein 2 (HIG2), a novel diagnostic marker for renal cell carcinoma and potential target for molecular therapy. Cancer Res 65 (2005) 4817
6. Zhong H., De Marzo A.M., Laughner E., Lim M., Hilton D.A., Zagzag D., et al. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastasis. Cancer Res 59 (1999) 5830
7. Baldwin A.S. The transcriptional factor NF-kB and human disease. J Clin Invest 107 (2001) 3
8. Haase V.H. The VHL/HIF oxygen-sensing pathway and its relevance to kidney disease. Kidney Int 69 (2006) 1302
9. Sizemore N., Lerner N., Dombrowski N., Sakurai H., and Stark G.R. Distinct roles of the IkB kinase α and β subunits in liberating nuclear factor kB (NFkB) from IkB and in phosphorylating the p65 subunit of NF-kB. J Biol Chem 277 (2002) 3863
10. Nadasdy T., Laszik Z., Lajoie G., Blick K.E., Wheeler D.E., and Silva F.G. Proliferative activity of cyst epithelium in human renal cystic diseases. J Am Soc Nephrol 5 (1995) 1462
11. Rosenberger C., Mandriota S., Jurgensen J.S., Wiesener M.S., Horstrup J.H., Frei U., et al. Expression of hypoxia-inducible factor-1α and -2α in hypoxia and ischemic rat kidney. J Am Soc Nephrol 13 (2002) 1721
12. Klahr S., and Morrissey J.J. The role of vasoactive compounds, growth factor and cytokines in the progression of renal disease. Kidney Int 57 (2000) S-7.
13. Oya M., Takayanagi A., Horiguchi A., Mizuno R., Ohtsubo M., Marumo K., et al. Increased nuclear factor-kB activation is related to the tumor development of renal cell carcinoma. Carcinogenesis 24 (2003) 377
14. Gnarra J., Tory K., Weng Y., Schmidt L., Wei M.H., Li H., et al. Mutation of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 7 (1994) 85
15. Parker A.S., Cheville J.C., Lohse C.M., Igel T., Leibovich B.C., and Blute M.L. Loss of expression of von Hippel-Lindau tumor suppressor protein associated with improved survival in patients with early-stage clear cell renal cell carcinoma. Urology 65 (2005) 1090
16. Turner K.J., Moore J.W., Jones A., Taylor C.F., Cuthbert-Heavens D., Han C., et al. Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation. Cancer Res 62 (2002) 2957
17. Jaakkola P., Mole D.R., Tian Y.M., Wilson M.I., Gielbert J., Gaskell S.J., et al. Targeting of HIF-α to the von Hippel-Lidau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292 (2001) 468
18. Oi H., and Ohh M. The von Hippel-Lindau tumor suppressor protein sensitizes renal cell carcinoma cells to tumor necrosis factor-induced cytotoxicity by suppressing the nuclear factor-kB-dependent antiapoptotic pathway. Cancer Res 63 (2003) 7076
19. Inoue H., Nonomura N., Kojima Y., Shiba M., Oka D., Arai Y., et al. Somatic mutations of the von Hippel-Lindau disease gene in renal carcinoma occurring in patients with long-term dialysis. Nephrol Dial Transplant 22 (2007) 2052
20. Gulanikar A.C., Daily P.P., Kilambi N.K., Hamrick-Turner J.E., and Butkus D.E. Prospective pretransplant ultrasound screening in 206 patients for acquired renal cysts and renal cell carcinoma. Transplantation 66 (1998) 1669